Yang Shen, PhD

Executive Director, Antibody Engineering & Bispecifics at Regeneron

Speaker

Yang Shen joined Regeneron in 2018 and currently serves as Executive Director for Bispecifics and Antibody Engineering Group. Yang founded Antibody Engineering Group and played instrumental role in establishing Altibody platform. He also served as co-chair for Protein Therapy, Pipeline and Technology Section at Regeneron. He and his team work on designing, producing and screening novel bispecifics and alternative format molecules to deepen our understanding of biology and to create new therapeutic opportunities at Regeneron. He received his Bachelor Degree in Biotechnology from Peking University, China and Ph.D. in Structural Biology from Columbia University. Prior to joining Regeneron, Yang held increasing roles at ImClone Systems and Eli Lilly between 2008 and 2018.